| ANOVA | Analysis of variance |
| BBB | Blood-brain barrier |
| BCG | Bacillus Calmette–Guérin |
| BW | Body weight |
| CFU | Colony-forming units |
| CNS | Central Nervous System |
| CMD | Common mental disorders |
| DEX | Dexamethasone |
| EAE | Experimental autoimmune encephalomyelitis |
| GCs | Glucocorticoids |
| GFAP | Glial fibrillary acidic protein |
| H | High |
| HPA | Hypothalamus-pituitary-adrenal axis |
| IL | Interleukin |
| IGCs | Inhaled GCs |
| IN | Intranasal delivery |
| IFNγ | Interferon-gamma |
| IV | Intravenously |
| L | Low |
| LMA | Locomotor activity |
| LPS | Lipopolysaccharide |
| M | Medium |
| MCAO | Middle cerebral artery occlusion |
| MDRTB | Multidrug-resistant TB |
| Mtb | Mycobacterium tuberculosis |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| OADC | Oleic acid, albumin, dextrose and catalase |
| pHDIPS | Protected head dips |
| REML | Mixed-effects model |
| ROS | Reactive oxygen species |
| SAP | Stretched attend postures |
| SEM | The standard error of the mean |
| TO | Time spent by mice on the open arm |
| TB | Tuberculosis |
| TNFα | Tumour necrosis factor-alpha |
| uHDIPS | Unprotected head dips |
| WHO | World Health Organization |